why choose us

First received: December 17, 2024

Clinical Trial: Gut Microbiome and Colorectal Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Colorectal Cancer

Study Type: OBSERVATIONAL


Official Title: Gut Microbiome Dyspiosis in Colorectal Cancer Egyptian Patients

Brief Summary: Colorectal cancer (CRC) is reported to be the third leading cause of cancer deaths worldwide, and its prevalence is steadily rising in developing countries.It can be considered a marker of socioeconomic development and a marker of significant changes in food habits and lifestyle.In Egypt, CRC represents the seventh most common cancer.It is the third most reported cancer in males and the fifth most common cancer in females.microbiome dysbiosis may be involved in the pathogensis and thus pose a therapeutic target

Read more